Trials / Unknown
UnknownNCT01594541
A Retrospective Analysis of Cerefolin NAC® in Cognitively Impaired Patients
Hyperhomocysteinemia in a Mild Cognitive Impairment and Dementia Population: the Effect of Treatment With Cerefolin NAC® in a Naturalistic Community-based Dementia Practice
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 700 (estimated)
- Sponsor
- Pamlab, Inc. · Industry
- Sex
- All
- Age
- 55 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
This retrospective analysis of de-identified data from 700 charts of consecutive patients from this patient population is to investigate the prevalence of hyperhomocysteinemia and associated metabolic abnormalities in this naturalistic grouping of patients with various stages of cognitive loss and diagnosed with various types of dementia.
Detailed description
A single-center, retrospective review of the medical charts of 700 de-identified elderly patients who underwent evaluation and treatment for cognitive loss including analysis of: Laboratory values of interest: homocysteine, methylmalonic acid, CRP, BNP, CO2, TSH, Fe/TIBC, RPR/TPPA/FTA-ABS, and if available, folic acid and B12 levels ordered by primary care providers. Neuropsychological tests of executive function, memory and affect: * Wechsler Memory Scale-Revised (WMS-R) or Fourth Edition (WMS-IV) * Logical Memory -Delayed Recall, Scaled Score * Visual Reproduction-Delayed Recall, Scaled Score * Shopping List Test, Delayed Recall * Trailmaking A and B Tests * Verbal Absurdities subtest of the Stanford Binet, Form L-M * Proverbs Test * Memory Orientation Screening Test * Folstein Mini-Mental State Exam * Geriatric Depression Scale, 15 items Sub-group analysis of MRI volumetrics and PET scans when available. Sequentially pulled from June 1, 2009 to September 2011
Conditions
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-08-01
- Completion
- 2014-04-01
- First posted
- 2012-05-09
- Last updated
- 2014-03-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01594541. Inclusion in this directory is not an endorsement.